Replies to post #115412 on Anavex Life Sciences Corp (AVXL)

[stockaesthetics]

Biogen is still pushing an awful drug for AD that they know barely works, yet some people on this board think that Biogen may have thrown in the towel with regards to a therapy for MS - their golden ticket therapeutic area which is now at risk due to Roche's new MS drug - which Anavex has already shown in some preclinical work to be efficacious for MS, that Biogen is now validating further. Crazy to think that rejecting 2-73 is the predominant possibility and not the possibility that a partnership with Biogen is possible.